abstract |
The present invention concerns hydrazinocarbonyl-thieno[2,3- c ]pyrazoles of formula (I): n n n n n n n n n n wherein R1, R3, R4, are R5 are as defined in the disclosure; their preparation method, compositions containing the same and their use for the treatment of pathological conditions, in particular as anticancer agents. |